Endo (ENDP) Tops Q3 EPS by 3c, Affirms FY Guidance

Go back to Endo (ENDP) Tops Q3 EPS by 3c, Affirms FY Guidance

Rationale for Endo (ENDP) Buyback 'Now Much Stronger', RBC Capital Says

November 6, 2015 8:30 AM EST

RBC Capital analyst Randall Stanicky lowered his price target on Endo International plc (NASDAQ: ENDP) to $91.00 (from $100.00) but maintained his Top Pick rating. The analyst said while the sell-off is hard to explain but rationale for buy-back is now much stronger.

On the weakness, the analyst pointed to several items: (i) the size of the write-down so soon after AUXL closed (1/29) (ii) the linkage to VRX and negative sector sentiment (iii) debate we heard around ability... More